Pizzolo et al. [138] reported that the hypertension phenotype of apparent mineralocorticoid excess was associated with higher methylation of the HSD11B2 promoter region compared with normotensive heterozygous relatives. This evidence concerns the gene HSD11B2 and Hypertension.